A flavonoid glycoside with diverse biological activities
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Avicularin

Item No. 33918

Technical Information
Formal Name
3-(α-L-arabinofuranosyloxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one
CAS Number
572-30-5
Synonyms
  • Quercetin 3-O-α-L-arabinofuranoside
Molecular Formula
C20H18O11
Formula Weight
Purity
≥98%
A solid
DMF: 50 mg/mlDMSO: 30 mg/mlEthanol: 5 mg/mlPBS (pH 7.2): insolu
λmax
258, 359 nm
SMILES
O=C(C(O[C@@H]1O[C@@H](CO)[C@H](O)[C@H]1O)=C(C2=CC(O)=C(C=C2)O)OC3=CC(O)=C4)C3=C4O
InChi Code
InChI=1S/C20H18O11/c21-6-13-15(26)17(28)20(30-13)31-19-16(27)14-11(25)4-8(22)5-12(14)29-18(19)7-1-2-9(23)10(24)3-7/h1-5,13,15,17,20-26,28H,6H2/t13-,15-,17+,20-/m0/s1
InChi Key
BDCDNTVZSILEOY-UXYNSRGZSA-N
Origin
Synthetic
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Avicularin is a flavonoid glycoside that has been found in R. sachalinensis and has diverse biological activities.1,2,3,4,5 It inhibits fatty acid synthase (FASN) and aldose reductase (IC50s = 6.15 and 19.05 µM for the chicken liver and human enzymes, respectively).1,2 Avicularin scavenges DPPH and superoxide radicals, as well as inhibits copper-induced oxidation of LDL in cell-free assays (IC50s = 64.3, 6, and 3.8 µM, respectively).3 It inhibits LPS-induced increases in nitric oxide (NO) and prostaglandin E2 (PGE2; Item No. 14010) production in RAW 264.7 macrophages when used at concentrations ranging from 30 to 300 µM.4 Avicularin (100 µg/ml) inhibits the proliferation, migration, and invasion of, as well as induces apoptosis and cell cycle arrest at the G0/G1 phase in, Huh7 hepatocellular carcinoma cells.5

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Abramson, H.N. The lipogenesis pathway as a cancer target. J. Med. Chem. 54(16), 5615-5638 (2011).

    2. Naeem, S., Hylands, P., and Barlow, D. Construction of an Indonesian herbal constituents database and its use in Random Forest modelling in a search for inhibitors of aldose reductase. Bioorg. Med. Chem. 20(3), 1251-1258 (2012).

    3. Zhang, X., Thuong, P.T., Jin, W., et alAntioxidant activity of anthraquinones and flavonoids from flower of Reynoutria sachalinensis. Arch. Pharm. Res. 28(1), 22-27 (2005).

    4. Vo, V.A., Lee, J.-W., Chang, J.-E., et alAvicularin inhibits lipopolysaccharide-induced inflammatory response by suppressing ERK phosphorylation in RAW 264.7 macrophages. Biomol. Ther. (Seoul) 20(6), 532-537 (2012).

    5. Wang, Z., Li, F., Quan, Y., et alAvicularin ameliorates human hepatocellular carcinoma via the regulation of NF‑κB/COX‑2/PPAR‑γ activities. Mol. Med. Rep. 19(6), 5417-5423 (2019).